The role of l-arginine/l-homoarginine/nitric oxide pathway for aortic distensibility and intima-media thickness in stroke patients

被引:0
|
作者
Arash Haghikia
Georgi Radoslavov Yanchev
Arslan Arinc Kayacelebi
Erik Hanff
Nils Bledau
Christian Widera
Kristina Sonnenschein
Aiden Haghikia
Karin Weissenborn
Johann Bauersachs
Udo Bavendiek
Dimitrios Tsikas
机构
[1] Hannover Medical School,Department of Cardiology and Angiology
[2] Charité Universitätsmedizin Berlin (Campus Benjamin Franklin),Department of Cardiology
[3] Hannover Medical School,Centre of Pharmacology and Toxicology
[4] Carl von Ossietzky University Oldenburg,Department of Cardiology, Heart Center Oldenburg, European Medical School Oldenburg
[5] Ruhr-University Bochum,Groningen
[6] Hannover Medical School,Department of Neurology
来源
Amino Acids | 2017年 / 49卷
关键词
AGAT; Cardiovascular disease; Aortic atherosclerosis and distensibility; GC–MS; Guanidino amino acids; Nitric oxide; Plasma;
D O I
暂无
中图分类号
学科分类号
摘要
Asymmetric dimethylarginine (ADMA) and l-homoarginine (hArg) are l-arginine (Arg) metabolites derived from different pathways. Protein arginine N-methyltransferase (PRMT) and subsequent proteolysis of proteins containing methylarginine residues release ADMA. Arginine:glycine amidinotransferase (AGAT) converts Arg to hArg and guanidinoacetate (GAA). While high concentrations of ADMA and low concentrations of hArg in the blood have been established as cardiovascular risk markers, the cardiovascular relevance of GAA is still unexplored. Arg and hArg are substrates and ADMA is an inhibitor of nitric oxide (NO) synthase (NOS). The cardiovascular effects of ADMA and hArg have been related to NO, a potent endogenous vasodilator. ADMA and hArg are considered to exert additional, not yet explored, presumably NO-unrelated effects and to act antagonistically in the renal and cardiovascular systems. Although the physiological role of Arg, ADMA, hArg and NO for endothelial function in small- and medium-sized arteries has been intensively studied in the past, the clinical relevance of aortic wall remodeling still remains unclear. Here, we evaluated potential relation between aortic distensibility (AD) or aortic intima-media thickness (aIMT) and circulating ADMA, hArg, GAA, and the NO metabolites nitrite and nitrate in the plasma of 78 patients (24 females, 54 males; aged 59 ± 14 years) with recent ischemic stroke or transient ischemic attack (TIA). All biochemical parameters were determined by stable-isotope dilution gas chromatography–mass spectrometry. AD and aIMT were measured by transesophageal echocardiography. Arg, hArg, ADMA and GAA median plasma concentrations (µM) were determined to be 61, 1.43, 0.50 and 2.16, respectively. hArg, ADMA and GAA correlated closely with Arg. Nitrite, nitrate and creatinine median plasma concentrations (µM) were 2.49, 48.7, and 84.1, respectively. Neither AD (2.61 vs. 1.85 10−6 × cm2 × dyn−1, P = 0.064) nor aIMT (1.25 vs. 1.13 mm, P = 0.596) differed between females and males. The hArg/ADMA molar ratio (r = −0.351, P = 0.009), nitrate (r = 0.364, P = 0.007) and nitrite (r = 0.329, P = 0.015) correlated with aIMT but not with AD. Arg, hArg, ADMA and GAA correlated with aIMT but not with AD. The results demonstrate a strong relation between the Arg/NO pathway and aortic atherosclerosis but not with AD suggesting different mechanisms underlying the two aspects of aortic wall remodeling.
引用
收藏
页码:1111 / 1121
页数:10
相关论文
共 50 条
  • [21] Effects of vitamin C on nitric oxide/L-arginine pathway in patients with atherosclerosis
    Tousoulis, D
    Davies, G
    Tentolouris, C
    Tousoulis, G
    Goumas, G
    Xenakis, C
    Pitsavos, C
    Brilli, S
    Antoniades, C
    Stefanadis, C
    Toutouzas, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 253A - 253A
  • [22] Impairment in the L-arginine nitric oxide pathway in patients with secondary arterial hypertension
    Mattei, P
    Virdis, A
    Ghiadoni, L
    Arzilli, F
    Bernini, G
    Taddei, S
    Salvetti, A
    JOURNAL OF HYPERTENSION, 1998, 16 : S86 - S86
  • [23] Activation of the L-arginine nitric oxide pathway in severe sepsis
    Duke, T
    South, M
    Stewart, A
    ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 76 (03) : 203 - 209
  • [24] MECHANISMS OF DISEASE - THE L-ARGININE NITRIC-OXIDE PATHWAY
    MONCADA, S
    HIGGS, A
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (27): : 2002 - 2012
  • [25] Role of the L-arginine/nitric oxide pathway in renal ischaemia-reperfusion in rats
    Rhoden, EL
    Pereira-Lima, L
    Rhoden, CR
    Lucas, ML
    Telöken, C
    Belló-Klein, A
    EUROPEAN JOURNAL OF SURGERY, 2001, 167 (03) : 224 - 228
  • [26] Role of L-arginine/nitric oxide pathway in the antinociceptive activities of morphine and mepyramine in mice
    Abacioglu, N
    Özmen, R
    Çakici, I
    Tunçtan, B
    Kanzik, I
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2001, 51 (12): : 977 - 983
  • [27] THE ROLE OF THE L-ARGININE/NITRIC OXIDE PATHWAY FOR RELAXATION OF THE HUMAN LOWER ESOPHAGEAL SPHINCTER
    TOTTRUP, A
    NY, L
    ALM, P
    LARSSON, B
    FORMAN, A
    ANDERSSON, KE
    ACTA PHYSIOLOGICA SCANDINAVICA, 1993, 149 (04): : 451 - 459
  • [28] Role of the L-arginine/nitric oxide pathway in ischaemic/reoxygenation injury of the human myocardium
    Zhang, JG
    Galiñanes, M
    CLINICAL SCIENCE, 2000, 99 (06) : 497 - 504
  • [29] ROLE OF L-ARGININE IN NITRIC OXIDE PRODUCTION IN HEALTH AND HYPERTENSION
    Rajapakse, Niwanthi W.
    Mattson, David L.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2009, 36 (03) : 249 - 255
  • [30] Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans
    Wu, Guoyao
    Meininger, Cynthia J.
    McNeal, Catherine J.
    Bazer, Fuller W.
    Rhoads, J. Marc
    AMINO ACIDS IN NUTRITION AND HEALTH: AMINO ACIDS IN GENE EXPRESSION, METABOLIC REGULATION, AND EXERCISING PERFORMANCE, 2021, 1332 : 167 - 187